Group One Trading’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,100
| Closed | -$39K | – | 7306 |
|
|
2020
Q3 | $39K | Buy |
4,100
+3,100
| +310% | +$29.5K | ﹤0.01% | 4801 |
|
|
2020
Q2 | $8K | Sell |
1,000
-1,600
| -62% | -$12.2K | ﹤0.01% | 5248 |
|
|
2020
Q1 | $16K | Sell |
2,600
-22,300
| -90% | -$196K | ﹤0.01% | 4366 |
|
|
2019
Q4 | $303K | Buy |
24,900
+12,700
| +104% | +$139K | ﹤0.01% | 2860 |
|
|
2019
Q3 | $141K | Sell |
12,200
-5,500
| -31% | -$57.9K | ﹤0.01% | 3338 |
|
|
2019
Q2 | $177K | Buy |
17,700
+300
| +2% | +$3.24K | ﹤0.01% | 2951 |
|
|
2019
Q1 | $224K | Sell |
17,400
-2,500
| -13% | -$37.2K | ﹤0.01% | 2608 |
|
|
2018
Q4 | $302K | Buy |
+19,900
| New | +$379K | ﹤0.01% | 2360 |
|
|
2018
Q3 | – | Sell |
-8,000
| Closed | -$156K | – | 5832 |
|
|
2018
Q2 | $156K | Sell |
8,000
-19,300
| -71% | -$427K | ﹤0.01% | 3247 |
|
|
2018
Q1 | $550K | Sell |
27,300
-1,200
| -4% | -$20.3K | 0.01% | 1986 |
|
|
2017
Q4 | $378K | Sell |
28,500
-37,300
| -57% | -$562K | ﹤0.01% | 2480 |
|
|
2017
Q3 | $1.21M | Sell |
65,800
-8,300
| -11% | -$155K | 0.01% | 1414 |
|
|
2017
Q2 | $1.36M | Buy |
74,100
+20,600
| +39% | +$408K | 0.01% | 1220 |
|
|
2017
Q1 | $1.21M | Buy |
53,500
+53,400
| +53,400% | +$1.28M | 0.01% | 1205 |
|
|
2016
Q4 | $3K | Sell |
100
-2,000
| -95% | -$59.8K | ﹤0.01% | 4214 |
|
|
2016
Q3 | $51K | Sell |
2,100
-1,300
| -38% | -$32.5K | ﹤0.01% | 3347 |
|
|
2016
Q2 | $81K | Sell |
3,400
-5,900
| -63% | -$135K | ﹤0.01% | 3008 |
|
|
2016
Q1 | $218K | Sell |
9,300
-5,500
| -37% | -$131K | ﹤0.01% | 2261 |
|
|
2015
Q4 | $447K | Buy |
14,800
+4,900
| +49% | +$158K | 0.01% | 1901 |
|
|
2015
Q3 | $393K | Buy |
9,900
+1,100
| +13% | +$68.3K | 0.01% | 1976 |
|
|
2015
Q2 | $608K | Buy |
8,800
+7,100
| +418% | +$447K | 0.01% | 1608 |
|
|
2015
Q1 | $93K | Buy |
1,700
+1,400
| +467% | +$66.7K | ﹤0.01% | 2948 |
|
|
2014
Q4 | $13K | Sell |
300
-700
| -70% | -$25.3K | ﹤0.01% | 4136 |
|
|
2014
Q3 | $32K | Sell |
1,000
-4,400
| -81% | -$93.8K | ﹤0.01% | 3840 |
|
|
2014
Q2 | $112K | Buy |
5,400
+4,000
| +286% | +$73.9K | ﹤0.01% | 2880 |
|
|
2014
Q1 | $27K | Buy |
+1,400
| New | +$29.7K | ﹤0.01% | 4067 |
|
Group One Trading's AMAG Position: Q1 2019 in Review
Group One Trading sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 16,288 shares — an estimated $243K sold.
Group One Trading first reported a position in AMAG in Q1 2014 and held it in 14 quarters. The position peaked at $894K in Q1 2017. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.
- Group One Trading reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 16,288 AMAG Pharmaceuticals shares in Q1 2019, an estimated $243K.
- Group One Trading first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 14 quarters.
- Group One Trading's AMAG Pharmaceuticals position peaked at $894K in Q1 2017.
- 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.